retatrutide type 2 diabetes phase 2 results 2024 2025 Lilly's triple agonist delivers up to 71.2 lbs of weight loss The MariTide phase 2 trial
Description
Diabetic control and healthy weight are beneficial for most chronic ocular diseases, including glaucoma, macular degeneration, and DED, as long as we help ensure that patients using GLP-1s achieve those goals by incorporating hydration and good nutrition

Its generally well-tolerated, and its side effect profile does not prominently include yeast infections
Current FDA-approved prescribing information for semaglutide does not require routine thyroid monitoring, including serum calcitonin measurements or thyroid ultrasound surveillance, in patients without risk factors
doi: 10.1111/acel.13297

if hair removal is necessary, patients should use scissors to trim rather than shaving, which can cause micro-abrasions
